Stempoint Capital LP
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Amylyx Pharmaceuticals, Inc. | $6.83M | 1.2% |
| Denali Therapeutics Inc. | $6.92M | 1.2% |
| JOHNSON & JOHNSON | $7.24M | 1.2% |
| NEKTAR THERAPEUTICS | $7.54M | 1.3% |
| BRIGHT MINDS BIOSCIENCES INC. | $7.60M | 1.3% |
| Edgewise Therapeutics, Inc. | $8.96M | 1.5% |
| Cytokinetics Inc | $9.34M | 1.6% |
| PALISADE BIO, INC. | $9.85M | 1.7% |
| Adaptive Biotechnologies Corp | $9.85M | 1.7% |
| MADRIGAL PHARMACEUTICALS, INC. | $10.33M | 1.8% |
| MINERALYS THERAPEUTICS INCMLYS | $10.53M | 1.8% |
| Celcuity Inc.CELC | $11.80M | 2.0% |
| Surrozen, Inc./DESRZN | $12.67M | 2.2% |
| Xenon Pharmaceuticals Inc. | $15.62M | 2.7% |
| Dyne Therapeutics, Inc. | $16.34M | 2.8% |
| Immunovant, Inc.IMVT | $16.39M | 2.8% |
| Twist Bioscience Corp | $16.44M | 2.8% |
| Terns Pharmaceuticals, Inc. | $17.34M | 3.0% |
| Roivant Sciences Ltd. | $20.98M | 3.6% |
| Arcellx, Inc. | $21.70M | 3.7% |
| Structure Therapeutics Inc.GPCR | $24.42M | 4.2% |
| Syndax Pharmaceuticals Inc | $28.14M | 4.8% |
| CENTESSA PHARMACEUTICALS PLC | $28.86M | 5.0% |
| Scholar Rock Holding Corp | $39.07M | 6.7% |
| ABIVAX SA | $52.83M | 9.1% |